SATTER MANAGEMENT CO., L.P.
Q2 2022 13F Holdings
- Locationchicago, IL
- Num holdings
7
- Value ($000)
$53,878
- Date Filed08/04/2022
- Form type13F-HR
- CIK0001844002
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2022 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
AMWL AMERICAN WELL CORP | CL A | 03044L105 | $27.22M | 51 % | 6,300,773 | ||
ANNX ANNEXON INC | COM | 03589W102 | $7.37M | 14 % | 1,954,978 | ||
V7B1 ASSEMBLY BIOSCIENCES INC | COM | 045396108 | $4.68M | 9 % | 2,227,500 | ||
AADI AADI BIOSCIENCES INC | COM | 00032Q104 | $4.62M | 9 % | 374,785 | ||
ALRN AILERON THERAPEUTICS INC | COM | 00887A105 | $4.32M | 8 % | 16,609,449 | ||
GBT GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | $4.03M | 8 % | 126,270 | ||
AKBA AKEBIA THERAPEUTICS INC | COM | 00972D105 | $1.64M | 3 % | 4,652,561 |
Rows Per Page
10
- 10
- 50
- 100